Compare Stocks

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGRL Aguia Resources	C$0.13 -7.1%	C$0.13	C$0.08 ▼ C$0.18	C$24.14M	N/A	418,301 shs	361,698 shs
ASND Ascendis Pharma A/S	$136.93 -4.4%	$149.08	$66.03 ▼ $161.00	$7.97B	0.5	368,318 shs	376,771 shs
DMI Diamcor Mining	C$0.05	C$0.06	C$0.05 ▼ C$0.16	C$6.43M	1.38	48,864 shs	4,000 shs
JZR JZR Gold	C$0.33 +32.0%	C$0.15	C$0.12 ▼ C$0.60	C$13.95M	1.1	42,235 shs	18,359 shs

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGRL Aguia Resources	0.00%	0.00%	0.00%	0.00%	0.00%
ASND Ascendis Pharma A/S	-1.14%	+0.71%	-0.89%	+8.68%	+82.72%
DMI Diamcor Mining	0.00%	0.00%	-16.67%	-23.08%	-61.54%
JZR JZR Gold	-16.67%	+25.00%	+108.33%	+56.25%	-56.90%

Thousands of investors use this no cost solution | Do you? (Ad)

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGRL Aguia Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	2.1337 of 5 stars	4.4	0.0	0.0	0.0	1.8	1.7	0.6
DMI Diamcor Mining	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
JZR JZR Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGRL Aguia Resources	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	2.88	Moderate Buy	$173.25	26.52% Upside
DMI Diamcor Mining	N/A	N/A	N/A	N/A
JZR JZR Gold	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest JZR, AGRL, DMI, and ASND Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/22/2024	ASND Ascendis Pharma A/S	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$116.00 ➝ $116.00
4/18/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
4/2/2024	ASND Ascendis Pharma A/S	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$165.00 ➝ $167.00
4/1/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
3/15/2024	ASND Ascendis Pharma A/S	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$196.00 ➝ $260.00
2/8/2024	ASND Ascendis Pharma A/S	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$146.00 ➝ $182.00
2/8/2024	ASND Ascendis Pharma A/S	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$207.00 ➝ $225.00
2/6/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$152.00 ➝ $173.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGRL Aguia Resources	C$-8.39K	-2,877.23	C$0.01 per share	14.00	C$0.19 per share	0.69
ASND Ascendis Pharma A/S	$288.08M	27.67	N/A	N/A	($2.73) per share	-50.16
DMI Diamcor Mining	C$2.17M	2.96	C$0.00 per share	48.75	C($0.03) per share	-1.67
JZR JZR Gold	N/A	N/A	C$0.00 per share	83.33	C$0.24 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGRL Aguia Resources	N/A	-C$0.01	N/A	∞	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	-$521.07M	-$9.25	N/A	N/A	N/A	-180.61%	-16,574.15%	-55.10%	4/25/2024 (Estimated)
DMI Diamcor Mining	-C$4.14M	-C$0.03	N/A	∞	N/A	-190.88%	N/A	-23.57%	8/6/2024 (Estimated)
JZR JZR Gold	-C$1.14M	C$0.01	33.00	∞	N/A	N/A	-13.12%	-6.50%	N/A

Latest JZR, AGRL, DMI, and ASND Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/25/2024	N/A	ASND Ascendis Pharma A/S	N/A	-$1.60	-$1.60	N/A	N/A	N/A
2/29/2024	Q3 2024	DMI Diamcor Mining	N/A	-C$0.01	-C$0.01	-C$0.01	N/A	C$0.05 million
2/7/2024	Q4 2023	ASND Ascendis Pharma A/S	-$2.15	-$1.66	+$0.49	-$1.66	$97.02 million	$148.62 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGRL Aguia Resources	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	N/A	N/A	N/A	N/A	N/A
DMI Diamcor Mining	N/A	N/A	N/A	N/A	N/A
JZR JZR Gold	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGRL Aguia Resources	N/A	1.61	1.48
ASND Ascendis Pharma A/S	N/A	3.56	2.50
DMI Diamcor Mining	617.97	0.06	0.13
JZR JZR Gold	10.69	0.12	0.07

Ownership

Institutional Ownership

Company	Institutional Ownership
AGRL Aguia Resources	N/A
ASND Ascendis Pharma A/S	N/A
DMI Diamcor Mining	N/A
JZR JZR Gold	N/A

Insider Ownership

Company	Insider Ownership
AGRL Aguia Resources	N/A
ASND Ascendis Pharma A/S	40.00%
DMI Diamcor Mining	38.57%
JZR JZR Gold	8.97%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AGRL Aguia Resources	N/A	185.67 million	N/A	Not Optionable
ASND Ascendis Pharma A/S	879	58.22 million	34.93 million	Optionable
DMI Diamcor Mining	N/A	128.51 million	N/A	Not Optionable
JZR JZR Gold	N/A	42.27 million	N/A	Not Optionable

JZR, AGRL, DMI, and ASND Headlines

Source	Headline
	JZR Gold Closes Non-Brokered Private Placement Offering Of Units And Provides Corporate Update goldseiten.de - April 16 at 10:20 AM
	JZR Gold Inc JZR morningstar.com - April 14 at 12:00 AM
	‘Simpsons’ Writer Calls Out ‘Jeopardy!’ for Botching A Piece of Sideshow Bob Trivia msn.com - March 16 at 8:25 AM
	Capital One Is Buying Discover: What Happens if You Bank With Either, or Both? msn.com - March 11 at 3:15 PM
	Apply for a Gold badge bbc.co.uk - March 9 at 4:15 PM
	I’m a Financial Advisor: Here’s How the Best $1,000 I Ever Spent Made Me Richer msn.com - March 8 at 5:42 PM
	Delta SkyMiles Gold Amex Card Review January 2024 latimes.com - January 18 at 9:08 AM
	JZR Gold Announces Private Placement Offering of Units to Raise Up to $1,000,000 thenewswire.com - December 19 at 12:09 AM
	JZR Gold Announces Appointment of Graham Carter to Board of Directors and as Chief Operating Officer juniorminingnetwork.com - December 12 at 9:43 PM
	JZR Gold Closes Non-Brokered Private Placement Offering of Units thenewswire.com - October 30 at 3:57 PM
	JZR Gold Announces Oversubscribed Private Placement thenewswire.com - October 23 at 8:34 PM
	Closing Bell: Jzr Gold Inc flat on Thursday (JZR) theglobeandmail.com - October 20 at 4:16 AM
	Closing Bell: Jzr Gold Inc down on Tuesday (JZR) theglobeandmail.com - October 4 at 8:43 AM
	Closing Bell: Jzr Gold Inc down on Monday (JZR) theglobeandmail.com - October 3 at 7:20 PM
	JZR Gold Announces Private Placement Offering of Units to Raise up to $600,000 thenewswire.com - October 2 at 7:39 PM
	Closing Bell: Jzr Gold Inc flat on Friday (JZR) theglobeandmail.com - September 30 at 9:09 AM
	Closing Bell: Jzr Gold Inc up on Friday (JZR) theglobeandmail.com - August 26 at 4:00 PM
	Closing Bell: Jzr Gold Inc down on Friday (JZR) theglobeandmail.com - August 22 at 5:00 PM
	JZR Gold Issues Bonus Shares in Connection with Loan Agreements goldseiten.de - August 18 at 11:20 PM
	JZR.V - JZR Gold Inc. finance.yahoo.com - July 19 at 1:45 AM
	U.S. Gold Bureau Reviews consumeraffairs.com - July 13 at 11:35 PM
	JZR Gold Closes First Tranche of Non-Brokered Private Placement Offering of Units goldseiten.de - April 27 at 11:05 AM
	JZR Gold Announces the Passing of Dr. Stewart Jackson and Amends the Terms of its Previously Announced Private Placement Offering thenewswire.com - April 22 at 4:04 AM
	JZR Gold Announces A Private Placement Offering of Common Shares to Raise up to $2.5 Million thenewswire.com - February 22 at 6:08 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aguia Resources

CVE:AGRL

Aguia Resources Limited engages in the exploration and development of mineral resource projects in Brazil. Its flagship Rio Grande phosphate assets include the Três Estradas, Joca Tavares, Porteira carbonatite, and Cerro Preto deposits located in the state of Rio Grande do Sul in southern Brazil. Aguia Resources Limited was incorporated in 2007 and is based in Belo Horizonte, Brazil.

Ascendis Pharma A/S

NASDAQ:ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Diamcor Mining

CVE:DMI

Diamcor Mining Inc., a junior mining and exploration company, identifies, acquires, explores for, evaluates, operates, and develops diamond-based resource properties. It holds interests in the Krone-Endora at Venetia project that consists of Krone 104MS and Endora 66MS farms covering a combined surface area of approximately 5,888 hectares located in South Africa. The company was incorporated in 1985 and is based in Kelowna, Canada.

JZR Gold

CVE:JZR

JZR Gold Inc., a junior mining resource company, engages in the exploration and development of mineral properties. Its flagship property is the Vila Nova gold development project located in Amapa, Brazil. The company was formerly known as Jazz Resources Inc. and changed its name to JZR Gold Inc. in October 2022. JZR Gold Inc. was incorporated in 1947 and is based in Surrey, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial